DERAPHAN - Trademark Details
Status: 700 - Registered
Image for trademark with serial number 87827876
Serial Number
87827876
Registration Number
5892113
Word Mark
DERAPHAN
Status
700 - Registered
Status Date
2019-10-22
Filing Date
2018-03-09
Registration Number
5892113
Registration Date
2019-10-22
Mark Drawing
4000 - Standard character mark Typeset
Published for Opposition Date
2018-07-24
Law Office Assigned Location Code
M50
Employee Name
ADEYIGA, ADETAYO JANET
Statements
Goods and Services
Allergy medications; Amino acid preparations for medical purposes; Antiallergic medicines; Cardiovascular agents for medical purposes; Cardiovascular pharmaceuticals; Cardiovascular treatment preparations; Dietary and nutritional supplements; Medical diagnostic reagents; Medical diagnostic reagents and assays for testing of body fluids; Medical diagnostic reagents for the analysis of body fluids; Nutraceuticals for use as a dietary supplement; Nutritional supplements; Pharmaceutical agents affecting digestive organs; Pharmaceutical agents affecting metabolism; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents for epidermis; Pharmaceutical agents for treating physically caused lesions; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical antitussive-cold preparations; Pharmaceutical for the treatment of erectile dysfunction; Pharmaceutical preparation for skin care; Pharmaceutical preparation for the treatment of gout; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for ocular or intraocular surgery; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical preparations for reducing sexual activity; Pharmaceutical preparations for skin care; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for the treatment of hypercholesteremia; Pharmaceutical preparations for the treatment of hyperlipidemia; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for the treatment of musculo-skeletal disorders; Pharmaceutical preparations for the treatment of worms in pets; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating allergies; Pharmaceutical preparations for treating and preventing tendon and muscle injuries and disorders, sports related injuries, and for knee cartilage regeneration; Pharmaceutical preparations for treating chemical imbalances; Pharmaceutical preparations for treating dandruff; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical preparations for wounds; Pharmaceutical preparations, namely, a blood clotting aid and delivery system for use in human and veterinary medicine; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical preparations, namely, a topical preparation for the treatment of ocular disorders prescribed by ophthalmologists, eye surgeons, and optometrists; Pharmaceutical preparations, namely, an analgesic for human consumption taken orally; Pharmaceutical preparations, namely, anticoagulants; Pharmaceutical preparations, namely, antidepressants; Pharmaceutical preparations, namely, antivirals; Pharmaceutical preparations, namely, appetite suppressants; Pharmaceutical preparations, namely, dantrolene sodium for injection; Pharmaceutical preparations, namely, injectable contraceptives; Pharmaceutical products and preparations against dry skin caused by pregnancy; Pharmaceutical products and preparations for chloasma; Pharmaceutical products and preparations for hydrating the skin during pregnancy; Pharmaceutical products and preparations for pregnancy blemishes; Pharmaceutical products and preparations for preventing skin blemishes during pregnancy; Pharmaceutical products and preparations to prevent stretch marks; Pharmaceutical products and preparations to prevent swelling in the legs; Pharmaceutical products for ophthalmological use; Pharmaceutical products for skin care for animals; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for the treatment of joint disease; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceutical skin lotions; Pharmaceuticals for the treatment of erectile dysfunction; Pharmaceuticals, namely, antihelmintics; Pharmaceuticals, namely, inducers of erections; Pharmaceuticals, namely, lipid lowering agents; Pharmaceuticals, namely, psychotropics; Preparations for the suppression of hormones; Preparations for the treatment of asthma; Preparations for the treatment of burns; Preparations for treating colds; Preparations to prevent nail-biting and thumb-sucking; Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of cardiovascular disorders
Translation of Words in Mark
The wording "DERAPHAN" has no meaning in a foreign language.
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2018-03-16
Primary Code
005
First Use Anywhere Date
2018-07-02
First Use In Commerce Date
2018-07-02
Current Trademark Owners
Party Name
Party Type
30 - Original Registrant
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
Party Type
30 - Original Registrant
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
21 - 1st New Owner After Publication
Address
Please log in with your Justia account to see this address.
Party Type
20 - Owner at Publication
Address
Please log in with your Justia account to see this address.
Party Type
10 - Original Applicant
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Sreenivasarao Vepachedu
Address
Please log in with your Justia account to see this address.
Trademark Events
Event DateEvent Description
2018-03-13NEW APPLICATION ENTERED IN TRAM
2018-03-16NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2018-03-15TEAS CHANGE OF CORRESPONDENCE RECEIVED
2018-04-03TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
2018-04-03ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
2018-06-21ASSIGNED TO EXAMINER
2018-06-21APPROVED FOR PUB - PRINCIPAL REGISTER
2018-07-04NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
2018-07-24PUBLISHED FOR OPPOSITION
2018-07-24OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2018-09-18NOA E-MAILED - SOU REQUIRED FROM APPLICANT
2018-09-18TEAS CHANGE OF CORRESPONDENCE RECEIVED
2018-09-18TEAS CHANGE OF OWNER ADDRESS RECEIVED
2018-09-18APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
2018-11-14TEAS STATEMENT OF USE RECEIVED
2018-12-01CASE ASSIGNED TO INTENT TO USE PARALEGAL
2018-11-14USE AMENDMENT FILED
2018-12-01STATEMENT OF USE PROCESSING COMPLETE
2018-12-05SU - NON-FINAL ACTION - WRITTEN
2018-12-05NON-FINAL ACTION E-MAILED
2018-12-05NOTIFICATION OF NON-FINAL ACTION E-MAILED
2019-02-18TEAS RESPONSE TO OFFICE ACTION RECEIVED
2019-02-22ASSIGNED TO LIE
2019-02-25APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
2019-02-25APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
2019-02-25CORRESPONDENCE RECEIVED IN LAW OFFICE
2019-02-25TEAS/EMAIL CORRESPONDENCE ENTERED
2019-02-25SU - FINAL REFUSAL - WRITTEN
2019-02-25FINAL REFUSAL E-MAILED
2019-02-25NOTIFICATION OF FINAL REFUSAL EMAILED
2019-03-01TEAS REQUEST FOR RECONSIDERATION RECEIVED
2019-03-05CORRESPONDENCE RECEIVED IN LAW OFFICE
2019-03-05TEAS/EMAIL CORRESPONDENCE ENTERED
2019-03-05ACTION REQ FOR RECON DENIED NO APPEAL FILED COUNTED NOT MAILED
2019-03-05ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED E-MAILED
2019-03-05NOTIFICATION FOR REQ FOR RECON DENIED NO APPEAL FILED
2019-03-05TEAS REQUEST FOR RECONSIDERATION RECEIVED
2019-03-05TEAS EXTENSION RECEIVED
2019-08-07AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
2019-09-18ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
2019-09-19NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
2019-10-22REGISTERED-PRINCIPAL REGISTER
2020-03-08TEAS CHANGE OF OWNER ADDRESS RECEIVED
2020-03-08TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
2020-03-08ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
2020-03-08TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
2020-03-08TEAS CHANGE OF CORRESPONDENCE RECEIVED
2020-03-08APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
2020-05-13CASE ASSIGNED TO POST REGISTRATION PARALEGAL
2020-06-11REVIEW OF CORRESPONDENCE COMPLETE - INFORMATION MADE OF RECORD